 | Up a level |
Hartlapp, Ingo, Alguel, Hana, Goekkurt, Eray, Siegler, Gabriele, Martens, Uwe, Waldschmidt, Dirk, Pelzer, Uwe 
ORCID: 0000-0001-9213-2737, Hennes, Elke, Fuchs, Martin, Siveke, Jens, Kullmann, Frank, Boeck, Stefan, Ettrich, Thomas J., Ferenczy, Peter, Keller, Ralph, Germer, Christoph-Thomas, Stein, Hubert, Klein, Ingo ORCID: 0000-0003-1097-0986, Heinemann, Volker and Kunzmann, Volker
(2020).
Induction Chemotherapy in Locally Advanced Pancreatic Cancer (LAPC) - Final Results of a Multicenter Randomized Phase 2 AIO Trial (NEOLAP).
Oncol. Res. Treat., 43.
S. 63 - 64.
BASEL:
KARGER.
ISSN 2296-5262
Kunzmann, Volker, Siveke, Jens T., Alguel, Hana, Goekkurt, Eray, Siegler, Gabriele, Martens, Uwe, Waldschmidt, Dirk, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Fuchs, Martin, Kullmann, Frank, Boeck, Stefan, Ettrich, Thomas J., Held, Swantje, Keller, Ralph, Klein, Ingo, Germer, Christoph-Thomas, Stein, Hubert, Friess, Helmut, Bahra, Marcus, Jakobs, Ralf, Hartlapp, Ingo and Heinemann, Volker
(2021).
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Lancet Gastroenterol. Hepatol., 6 (2).
S. 128 - 139.
SAN DIEGO:
ELSEVIER INC.
ISSN 2468-1253